Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2015 4
2016 2
2017 3
2018 3
2019 2
2020 6
2021 9
2022 14
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Long-term risk prediction after major lower limb amputation: 1-year results of the PERCEIVE study.
Gwilym BL, Pallmann P, Waldron CA, Thomas-Jones E, Milosevic S, Brookes-Howell L, Harris D, Massey I, Burton J, Stewart P, Samuel K, Jones S, Cox D, Clothier A, Prout H, Edwards A, Twine CP, Bosanquet DC; Vascular and Endovascular Research Network (VERN) and the PERCEIVE study group. Gwilym BL, et al. Among authors: pallmann p. BJS Open. 2024 Jan 3;8(1):zrad135. doi: 10.1093/bjsopen/zrad135. BJS Open. 2024. PMID: 38266124 Free PMC article.
Developing a model for decision-making around antibiotic prescribing for patients with COVID-19 pneumonia in acute NHS hospitals during the first wave of the COVID-19 pandemic: qualitative results from the Procalcitonin Evaluation of Antibiotic use in COVID-19 Hospitalised patients (PEACH Study).
Henley J, Brookes-Howell L, Euden J, Pallmann P, Llewelyn M, Howard P, Powell N, Dark P, Szakmany T, Hellyer TP, Albur M, Hamilton R, Prestwich G, Ogden M, Maboshe W, Sandoe J, Thomas-Jones E, Carrol E; PEACH study group (Procalcitonin Evaluation of Antibiotic use in COVID-19 Hospitalised patients); PEACH consortium (Procalcitonin Evaluation of Antibiotic use in COVID-19 Hospitalised patients). Henley J, et al. Among authors: pallmann p. BMJ Open. 2023 Dec 19;13(12):e077117. doi: 10.1136/bmjopen-2023-077117. BMJ Open. 2023. PMID: 38114276 Free PMC article.
Correction: Medicines and Healthcare products Regulatory Agency's "Consultation on proposals for legislative changes for clinical trials": a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharing.
Law M, Couturier DL, Choodari-Oskooei B, Crout P, Gamble C, Jacko P, Pallmann P, Pilling M, Robertson DS, Robling M, Sydes MR, Villar SS, Wason J, Wheeler G, Williamson SF, Yap C, Jaki T. Law M, et al. Among authors: pallmann p. Trials. 2023 Nov 21;24(1):744. doi: 10.1186/s13063-023-07763-6. Trials. 2023. PMID: 37990330 Free PMC article. No abstract available.
Medicines and Healthcare products Regulatory Agency's "Consultation on proposals for legislative changes for clinical trials": a response from the Trials Methodology Research Partnership Adaptive Designs Working Group, with a focus on data sharing.
Law M, Couturier DL, Choodari-Oskooei B, Crout P, Gamble C, Jacko P, Pallmann P, Pilling M, Robertson DS, Robling M, Sydes MR, Villar SS, Wason J, Wheeler G, Williamson SF, Yap C, Jaki T. Law M, et al. Among authors: pallmann p. Trials. 2023 Oct 5;24(1):640. doi: 10.1186/s13063-023-07576-7. Trials. 2023. PMID: 37798805 Free PMC article.
Biomarker-guided duration of antibiotic treatment in children hospitalised with confirmed or suspected bacterial infection: statistical analysis plan for the BATCH trial and PRECISE sub-study.
Schoenbuchner SM, Huang C, Waldron CA, Thomas-Jones E, Hood K, Carrol ED, Pallmann P. Schoenbuchner SM, et al. Among authors: pallmann p. Trials. 2023 May 30;24(1):364. doi: 10.1186/s13063-022-06956-9. Trials. 2023. PMID: 37254156 Free PMC article. Clinical Trial.
A tutorial comparing different covariate balancing methods with an application evaluating the causal effects of substance use treatment programs for adolescents.
Markoulidakis A, Taiyari K, Holmans P, Pallmann P, Busse M, Godley MD, Griffin BA. Markoulidakis A, et al. Among authors: pallmann p. Health Serv Outcomes Res Methodol. 2023;23(2):115-148. doi: 10.1007/s10742-022-00280-0. Epub 2022 May 27. Health Serv Outcomes Res Methodol. 2023. PMID: 37207016 Free PMC article.
Effectiveness and cost-effectiveness of a personalised self-management intervention for living with long COVID: protocol for the LISTEN randomised controlled trial.
Potter C, Leggat F, Lowe R, Pallmann P, Riaz M, Barlow C, Edwards A, Siriwardena AN, Sevdalis N, Sewell B, McRae J, Fish J, de Sousa de Abreu MI, Jones F, Busse M. Potter C, et al. Among authors: pallmann p. Trials. 2023 Feb 1;24(1):75. doi: 10.1186/s13063-023-07090-w. Trials. 2023. PMID: 36726167 Free PMC article.
51 results